Khosla Ventures related stories
All articles and analysis
VC-backed Zenefits taps Wiley as CFOSan Francisco-based Zenefits, a digital human resources platform for small and medium-sized businesses, has named Shaun Wiley as chief financial officer. Previously, Wiley was CFO of CoreHR. Zenefits' backers include Andreessen Horowitz, TPG Growth, Founders Fund, Khosla Ventures and Insight Venture Partners.
Tencent to invest $50 mln in storytelling platform WattpadToronto storytelling app Wattpad will soon receive about $50 million (US$40 million) from an investment by China's Tencent Holdings, according to a report https://www.wsj.com/articles/ritual-gobbles-up-43-million-for-order-ahead-dining-app-1506339041 by the Globe and Mail. The investment will form part of a new US$50 million financing of Wattpad, to be finalized in the weeks ahead, the report said. The round, which will be backed by a mix of Canadian and U.S. venture capital firms, is expected to value the company at about US$400 million. Founded in 2006 by CEO Allen Lau and CPO Ivan Yuen, Wattpad operates a social platform that creates direct connections between readers and writers. In 2014, it raised US$46 million in a Series C financing led by OMERS Ventures.
- Google buys VC-backed 60dB
Google has acquired 60dB, a curator and streamer of short-form audio news, the latter announced in https://medium.com/@60dB/good-night-and-good-news-844f00d55417 a blog post on its site. No financial terms were disclosed. 60dB will be shutting down on November 10, 2017 and its team will join Google. 60dB's backers included Khosla Ventures.
- Deep Genomics lands $13 mln in follow-on round led by Khosla
Deep Genomics, a Toronto genetic medicine startup, has raised $13 million in follow-on financing. Khosla Ventures led the round and was joined by True Ventures, which led the company’s $5 million seed financing in 2015. Spun out of the University of Toronto in 2014, Deep Genomics is building a biologically accurate, data- and artificial intelligence-driven technology platform that supports geneticists, molecular biologists and chemists in the development of therapies.
- Eligo Bioscience reels in $20 mln Series A
Paris-based Eligo Bioscience, a microbiome company developing drugs to prevent and treat bacteria-associated diseases, has secured $20 million in Series A financing. The investors included Khosla Ventures and Seventure Partners.
Deep Genomics lands $16 mln in follow-on round led by KhoslaDeep Genomics, a Toronto genetic medicine startup, has raised about $16 million (US$13 million) in follow-on financing. U.S. venture capital firm Khosla Ventures led the round and was joined by True Ventures, which led the company's $5 million seed financing in 2015 /canada/2015/11/deep-genomics-reels-in-c5-mln/ Spun out of the University of Toronto in 2014, Deep Genomics is building a biologically accurate, data- and artificial intelligence-driven technology platform that supports geneticists, molecular biologists and chemists in the development of therapies. It will use its platform to unlock new classes of anti-sense oligonucleotide therapies and advance them for clinical evaluation. Deep Genomics is led by CEO Brendan Frey.
- Ellevest rakes in $34.6 mln
Ellevest, a digital investment platform for women, has secured $34.6 million in funding. Rethink Impact led the round with participation from other investors that included PSP Growth, Salesforce Ventures, CreditEase Fintech Investment Fund, LH Holdings, SK Impact Fund, LLC, Morningstar, Khosla Ventures, Mellody Hobson, Ulu Ventures, Contour Venture Partners and Astia Angels. In addition to the funding, Jenny Abramson, Rethink Impact’s founder and managing partner, will join Ellevest's board.